MESA LABS DECLARES QUARTERLY DIVIDEND
January 09 2020 - 7:00PM
Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or
the “Company”) today announced that its Board of Directors has
declared a regular quarterly dividend of $0.16 per share of common
stock. The dividend will be payable on March 16, 2020, to
shareholders of record at the close of business on February 28,
2020.
About Mesa Laboratories, Inc.
Mesa is a global technology innovator committed to solving some
of the most critical quality control challenges in the
pharmaceutical, healthcare, industrial safety, environmental and
food and beverage industries. Mesa offers products and
services through five divisions (Sterilization and Disinfection
Control, Biopharmaceutical Development, Instruments, Cold Chain
Monitoring and Cold Chain Packaging) to help our customers ensure
product integrity, increase patient and worker safety, and improve
the quality of life throughout the world.
Forward Looking StatementsThis press release may contain
information that constitutes "forward-looking statements."
Generally, the words "believe," “estimate,” “intend,” "expect,"
"project," “anticipate,” "will" and similar expressions identify
forward-looking statements, which generally are not historical in
nature. However, the absence of these words or similar expressions
does not mean that a statement is not forward-looking. All
statements that address operating performance, events or
developments that we expect or anticipate will occur in the future
— including statements relating to revenues growth and statements
expressing general views about future operating results — are
forward-looking statements. Management believes that these
forward-looking statements are reasonable as and when made.
However, caution should be taken not to place undue reliance on any
such forward-looking statements because such statements speak only
as of the date when made. We undertake no obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
required by law. In addition, forward-looking statements are
subject to certain risks and uncertainties that could cause actual
results to differ materially from our historical experience and
present expectations or projections. These risks and uncertainties
include, but are not limited to, those described in our Annual
Report on Form 10-K for the year ended March 31, 2019, and those
described from time to time in our subsequent reports filed with
the Securities and Exchange Commission.
For more information about the Company, please visit its website
at www.mesalabs.com
CONTACT: Gary Owens.; President and CEO, or John Sakys; CFO, both of Mesa Laboratories, Inc., +1-303-987-8000
Mesa Laboratories (NASDAQ:MLAB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Mesa Laboratories (NASDAQ:MLAB)
Historical Stock Chart
From Sep 2023 to Sep 2024